City

London (1)

Monterrey (1)

Rochester (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 4 (1)

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez (1)

Mayo Clinic (1)

Momentum Data (1)

Collaborator

Pfizer (1)

University of Oxford (1)

University of Surrey (1)

Intervention

exposure of interest (studies 2 & 3). (1)

hydroxocobalamin 10,000mcg, thiamin 100mg, pyridoxine 50mg (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

pernicious anemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Associated Burden of Related Conditions in Alopecia Areata

Completed

Alopecia Areata
+35 more

Exposure of interest (studies 2 & 3).

London, United Kingdom

Momentum Data Ltd

Dec 13, 2022

Megaloblastic Anemia Nos, Pernicious Anemia Trial in Monterrey (Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg)

Completed

Megaloblastic Anemia Nos
Pernicious Anemia

Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg

Monterrey, Nuevo Leon, Mexico

Hospital Universitario Dr. Jose E Gonzalez UANL

Mar 5, 2021

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Completed

SCAD
+28 more

Rochester, Minnesota

Mayo Clinic

Nov 20, 2020